|
|
| | ANTI-CIP1 Basic information |
| Product Name: | ANTI-CIP1 | | Synonyms: | Monoclonal Anti-D4S234E antibody produced in mouse;ANTI-WAF1 (AB-1) FITC CONJ;ANTI-WAF;ANTI-WAF (AB-1), HUMAN FLUORESCEIN CONJUGATE;ANTI-WAF (AB-1) MOUSE MAB FLUORESCEIN CONJUGATE;ANTI-SD1 (AB-1), HUMAN FLUORESCEIN CONJUGATE;ANTI-SD11 (AB-1) MOUSE MAB FLUORESCEIN CONJUGATE;ANTI-SD11 | | CAS: | | | MF: | | | MW: | 0 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File | ![ANTI-CIP1 Structure]() |
| | ANTI-CIP1 Chemical Properties |
| storage temp. | -20°C | | form | buffered aqueous solution |
| | ANTI-CIP1 Usage And Synthesis |
| General Description | This gene encodes a potent cyclin-dependent kinase inhibitor. The encoded protein binds to and inhibits the activity of cyclin-CDK2 or -CDK4 complexes, and thus functions as a regulator of cell cycle progression at G1. The expression of this gene is tightly controlled by the tumor suppressor protein p53, through which this protein mediates the p53-dependent cell cycle G1 phase arrest in response to a variety of stress stimuli. This protein can interact with proliferating cell nuclear antigen (PCNA), a DNA polymerase accessory factor, and plays a regulatory role in S phase DNA replication and DNA damage repair. This protein was reported to be specifically cleaved by CASP3-like caspases, which thus leads to a dramatic activation of CDK2, and may be instrumental in the execution of apoptosis following caspase activation. Two alternatively spliced variants, which encode an identical protein, have been reported. (provided by RefSeq) |
| | ANTI-CIP1 Preparation Products And Raw materials |
|